subject area of
- A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer Journal Articles
- ATM regulates proteasome-dependent subnuclear localization of TRF1, which is important for telomere maintenance Journal Articles
- Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study. Journal Articles
- Glucosamine-Induced Endoplasmic Reticulum Stress Promotes ApoB100 Degradation Journal Articles
- Proteasomal Regulation of Cardiac Hypertrophy Journal Articles
- Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle Journal Articles
- Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis Journal Articles
- Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis. Journal Articles
- Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world” Journal Articles
- The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors Journal Articles
- The Ubiquitin–Proteasome System and Cardiovascular Disease Journal Articles